Q3 2019 Investor Presentation slide image

Q3 2019 Investor Presentation

Summary The portfolio is financially attractive on its own and we have leading positions in key segments. ©2019 ResMed I Q3 2019 Investor Presentation | 29 $ Supports growth for existing businesses (HME) and chronic diseases, sleep apnea and COPD in particular. The ecosystem and scale creates our competitive advantage. ResMed
View entire presentation